IDSA: EHR Order Set Reduces Antibiotic Duration in Children With AOM
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 17, 2024 -- Implementation of an electronic health record (EHR) order set increases compliance with the recommended duration of prescribed antibiotics for children with acute otitis media (AOM), according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.
Joana Dimo, D.O., from the University of Colorado/Children's Hospital Colorado in Denver, and colleagues examined the impact of a quality improvement intervention on antibiotic prescribing for pediatric AOM. The bundled intervention included an EHR order set that preselected a five-day antibiotic duration for children aged 24 months and older and creation of a local clinical care pathway, which encouraged observation and pain management in children aged 24 months and older and those aged 6 to 23 months with unilateral, nonsevere AOM. Patients aged 61 days to 18 years presenting to emergency departments and urgent care centers were reviewed; data were included for 34,324 patients.
The researchers found that throughout the study, rates of antibiotic prescribing remained high (88 to 93 percent), with special cause variation. After development of the EHR order set, there was an increase in compliance with the recommended duration of antibiotics of five days or fewer (3 to 83 percent). Throughout the study, the rates of amoxicillin prescribing decreased (77 to 74 percent).
"Reducing the duration of antibiotic regimens will help treatments remain effective in the face of increasing, dangerous antimicrobial resistance and prevent harm from antibiotics," Dimo said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-18 12:00
Read more
- Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
- Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
- Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two Decades
- Poor Sleep Quality Linked to Incident Motoric Cognitive Risk Syndrome
- Vitamin D Supplements Could Help Lower Blood Pressure in Obese People
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions